GWAS Data Translating Into Improved Drug Safety, Researchers Say | GenomeWeb

By Andrea Anderson

SAN DIEGO (GenomeWeb News) – While genome-wide association studies have long been considered an avenue for improving diagnostics, prognostics, and treatment, their most immediate application appears to be for improving drug safety and decreasing adverse events, according to Lon Cardon, senior vice president of GlaxoSmithKline's genetics program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.